News
A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel ...
These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.
The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their ...
A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand ...
Multivalent agents (including antibodies, soluble receptors and cytokines) address immune suppression and T cell exhaustion ...
Learn how soluble B-cell maturation antigen contributes to the effectiveness of targeted immunotherapies.
Recent advancements in dermatology have highlighted the crucial role of dermal T cell immunity in regulating hair follicle ...
6d
AZoLifeSciences on MSNAI-Powered Protein Design Opens Doors to New T-Cell Based Immunotherapies
A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...
Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone ...
BriaCell's subsidiary, BriaPro seeks patent for immuno-oncology platform with novel multitargeting agents: Philadelphia Thursday, July 31, 2025, 17:00 Hrs [IST] BriaCell Therapeut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results